#ITI#A dose-response study of inactivated low pathogenic avian influenza H9N2 virus in specific-pathogen-free and commercial broiler chickens#FTI#
#IRE#Since the first report of low pathogenic avian influenza (LPAI) H9N2 virus in Egypt in 2011, the Egyptian poultry industry has suffered from unexpected economic losses as a result of the wide spread of LPAI H9N2. Hence, inactivated H9N2 vaccines have been included in the vaccination programs of different poultry production sectors. The optimal antigen content of avian influenza virus vaccines is essential to reach protective antibody titers. In this study, the correlation between antigen content (based on hemagglutinating units [HAU]) and postvaccination (PV) antibody response of H9N2 inactivated vaccine was studied. Five different vaccine antigen loads (128, 200, 250, 300, and 350 HAU formulas/dose) were investigated in commercial broiler and specific-pathogen-free (SPF) chickens. Vaccine safety and PV antibody responses were monitored. At the fourth week PV only SPF vaccinated groups (128, 200, 250, and 300 HAU/dose) were challenged using LPAI H9N2 (A/Ck/EG/114940v/ NLQP/11) virus with 106 EID50/bird. Oropharyngeal swabs were used to monitor virus shedding at 2, 4, 6, and 10 days postchallenge. Results showed that all vaccine formulations were well tolerated, and the highest antibody titers were observed in birds vaccinated with higher HAU. Vaccines containing 128 and 200 HAU/dose did not induce the required protective HI titers by 3 wk PV. Meanwhile, the challenge experiment in SPF chickens showed that 250 and 300 HAU vaccine doses were required to reduce the level and duration of virus shedding. Study results thus suggest that inactivated H9N2 vaccines containing at least 250 HAU/dose will induce the optimal protective titers and minimize virus shedding in SPF chickens.#FRE#
#IPC#Avian influenza; Chickens; H9N2; Inactivated vaccine#FPC#
#IRF#Abdel-Moneim A.S., Afifi M.A., El-Kady M.F., Isolation and mutation trend analysis of influenza a virus subtype h9n2 in Egypt, Virol. J., 9, (2012); 
Capua I., Terregino C., Cattoli G., Toffan A., Increased resistance of vaccinated turkeys to experimental infection with an h7n3 lowpathogenicity avian influenza virus, Avian Pathol, 33, pp. 158-163, (2004); 
Choi J.G., Lee Y.J., Kim Y.J., Lee E.K., Jeong O.M., Sung H.W., Kim J.H., Kwon J.H., An inactivated vaccine to control the current h9n2 low pathogenic avian influenza in Korea, J. Vet. Sci, 9, pp. 67-74, (2008); 
Cox N.J., Fuller F., Kaverin N., Klenk H.D., Lamb R.A., Mahy B.W.J., McCauley J.W., Nakamura K., Palese P., Webster R.G., Family orthomyxoviridae, Virus Taxonomy Classification and Nomenclature of Viruses, pp. 585-597, (2000); 
Ducatez M.F., Webster R.G., Webby R.J., Animal influenza epidemiology, Vaccine, 26, pp. D67-D69, (2008); 
El-Zoghby E.F., Arafa A.S., Hassan M.K., Aly M.M., Selim A., Kilany W.H., Selim U., Nasef S., Aggor M.G., Abdelwhab E.M., Hafez H.M., Isolation of h9n2 avian influenza virus from bobwhite quail (colinus virginianus) in Egypt, Arch. Virol, 157, pp. 1167-1172, (2012); 
Fouchier R.A., Munster V., Wallensten A., Bestebroer T.M., Herfst S., Smith D., Rimmelzwaan G.F., Olsen B., Osterhaus A.D., Characterization of a novel influenza a virus hemagglutinin subtype (H16) obtained from black-headed gulls, J. Virol, 79, pp. 2814-2822, (2005); 
Fusaro A., Monne I., Salviato A., Valastro V., Schivo A., Amarin N.M., Gonzalez C., Ismail M.M., Al-Ankari A.R., Al-Blowi M.H., Khan O.A., Ali A.S.M., Hedayati A., Garcia J.G., Ziay G.M., Shoushtari A., Qahtani K.N.A., Capua I., Holmes E.C., Cattoli G., Phylogeography and evolutionary history of reassortant h9n2 viruses with potential human health implications, J. Virol, 85, pp. 8413-8421, (2011); 
Halvorson D.A., The control of h5 or h7 mildly pathogenic avian influenza: A role for inactivated vaccine, Avian Pathol, 31, pp. 5-12, (2002); 
Kandeil A., El-Shesheny R., Maatouq A.M., Moatasim Y., Shehata M.M., Bagato O., Rubrum A., Shanmuganatham K., Webby R.J., Ali M.A., Kayali G., Genetic and antigenic evolution of h9n2 avian influenza viruses circulating in Egypt between 2011 and 2013, Arch. Virol, 159, pp. 2861-2876, (2014); 
Kilany W., Dauphin G., Selim A., Tripodi A., Samy M., Sobhy H., VonDobschuetz S., Safwat M., Saad M., Erfan A., Hassan M., Lubroth J., Jobre Y., Protection conferred by recombinant Turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt, Avian Pathol, 43, pp. 514-523, (2014); 
Kilany W.H., Hassan M.K., Safwat M., Mohammed S., Selim A., VonDobschuetz S., Dauphin G., Lubroth J., Jobre Y., Comparison of the effectiveness of rHVT-H5, inactivated h5 and rHVT-H5 with inactivated h5 prime/boost vaccination regimes in commercial broiler chickens carrying mdas against hpai h5n1 clade 2.2.1 virus, Avian Pathol, 44, pp. 333-341, (2015); 
Maas R., Tacken M., Zoelen D.V., Oei H., Dose response effects of avian influenza (H7N7) vaccination of chickens: Serology, clinical protection and reduction of virus excretion, Vaccine, 27, pp. 3592-3597, (2009); 
Monne I., Hussein H.A., Fusaro A., Valastro V., Hamoud M.M., Khalefa R.A., Dardir S.N., Radwan M.I., Capua I., Cattoli G., H9n2 influenza a virus circulates in h5n1 endemically infected poultry population in Egypt, Influenza other Respi Viruses, 7, pp. 240-243, (2013); 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. [Internet]. World Organisation for Animal Health; 
Peiris J.S., Jong M.D.D., Guan Y., Avian influenza virus (H5N1): A threat to human health, Clin. Microbiol. Rev, 20, pp. 243-267, (2007); 
Peyre M., Samaha H., Makonnen Y.J., Saad A., Abd-Elnabi A., Galal S., Ettel T., Dauphin G., Lubroth J., Roger F., Domenech J., Avian influenza vaccination in Egypt: Limitations of the current strategy, J. Mol. Genet. Med, 3, pp. 198-204, (2009); 
Reed L.J., Muench H., A simple method of estimating fifty per cent endpoint, Am. J. Hyg, 27, pp. 493-497, (1938); 
Richard-Mazet A., Goutebroze S., Gros F.X.L., Swayne D.E., Bublot M., Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with xmaternal antibodies, Vet. Res, 45, (2014); 
Sasaki T., Isoda N., Soda K., Sakamoto R., Saijo K., Hagiwara J., Kokumai N., Ohgitani T., Imamura T., Sawata A., Lin Z., Sakoda Y., Kida H., Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from h5n1 virus, Jpn. J. Vet, Res, 56, pp. 189-198, (2009); 
Spackman E., Wan X.F., Kapczynski D., Xu Y., Pantin-Jackwood M., Suarez D.L., Swayne D., Potency, efficacy, and antigenic mapping of h7 avian influenza virus vaccines against the 2012 h7n3 highly pathogenic avian influenza virus from Mexico, Avian Dis, 58, pp. 359-366, (2014); 
Swayne D.E., Beck J.R., Garcia M., Stone H.D., Influence of virus strain and antigen mass on efficacy of h5 avian influenza inactivated vaccines, Avian Pathol, 28, pp. 245-255, (1999); 
Swayne D.E., Kapczynski D., Strategies and challenges for eliciting immunity against avian influenza virus in birds, Immunol. Rev, 225, pp. 314-331, (2008); 
Swayne D.E., Suarez D.L., Spackman E., Jadhao S., Dauphin G., Kim-Torchetti M., McGrane J., Weaver J., Daniels P., Wong F., Selleck P., Wiyono A., Indriani R., Yupiana Y., Siregar E.S., Prajitno T., Smith D., Fouchier R., Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic drift variants of h5n1 high pathogenicity avian influenza viruses from Indonesia, J. Virol, 89, pp. 3746-3762, (2015); 
Webster R.G., Webby R.J., Hoffmann E., Rodenberg J., Kumar M., Chu H.J., Seiler P., Krauss S., Songserm T., The immunogenicity and efficacy against h5n1 challenge of reverse genetics-derived h5n3 influenza vaccine in ducks and chickens, Virology, 351, pp. 303-311, (2006); 
Wood J.M., Kawaoka Y., Newberry L.A., Bordwell E., Webster R.G., Standardization of inactivated h5n2 influenza vaccine and efficacy against lethal a/chicken/Pennsylvania/1370/83 infection, Avian Dis, 29, pp. 867-872, (1985)#FRF#
